Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)

View source ↗

Summary

The document reports a clinical trial evaluating garadacimab for hereditary angioedema. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Garadacimab (garadacimab)

Snippet

Sponsor: CSL Behring | Conditions: Hereditary Angioedemas | Status: RECRUITING